Here are four notes:
1. Stryker agreed to acquire all of Invuity’s outstanding shares for $7.40 per share, for a total of about $190 million. Stryker plans to finance the transaction using cash.
2. After the acquisition closes, a Stryker subsidiary will merge with and into Invuity, and Invuity will be taken private. Invuity’s board of directors approved the transaction.
3. The transaction is expected to close in the fourth quarter, subject to customary conditions and regulatory approvals.
4. Invuity develops advanced surgical devices to enhance visualization.
“The combination of Stryker’s established leadership in minimal access surgery paired with Invuity’s suite of enabling visualization and surgical devices should facilitate better patient outcomes and operating room efficiencies in women’s health, general surgery, electrophysiology and orthopedics,” said Scott Flora, Invuity’s Interim CEO.
More articles on supply chain:
ASC supply chain tip of the day: Shop your distributor & GPO provider contracts regularly
ASC supply chain tip of the day: Copy what works at hospitals
3 Ways to cut operating room inventory in an ASC
